Study of AV-1959D, an Amyloid Beta Vaccine
Clinical trial NCT05642429 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05642429
- Sponsor
- Institute for Molecular Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-27
- Primary completion
- 2026-07-20
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.